Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.

BACKGROUND We previously reported selective decreases of neocortical volumes in patients with early relapsing-remitting (RR) multiple sclerosis (MS) with mild cognitive impairment, with a good correlation between cortical volumes and cognitive measures. OBJECTIVE To assess the relevance of gray matter changes over time to changes in cognition in RRMS. DESIGN A longitudinal survey after 2.5 years. Each patient underwent a magnetic resonance imaging (MRI) protocol identical to that performed at baseline; cognitive performance was reassessed with the Rao Brief Repeatable Battery of Neuropsychological Tests in Multiple Sclerosis. SETTING Two university MS clinics. PATIENTS Of 41 patients with RRMS who participated in the original cross-sectional study, 28 were available for the follow-up evaluation (18 women; mean +/- SD age, 37.1 +/- 8.9 years; mean +/- SD MS duration, 7.3 +/- 2.9 years; mean +/- SD Expanded Disability Status Scale score, 1.8 +/- 1.5). MAIN OUTCOME MEASURES We measured the percentage of brain volume changes, normalized cortical volume (NCV) changes, and normalized deep gray matter volume changes on conventional T1-weighted MRIs and changes in lesion load on T2-weighted MRIs. The number of tests failed on the Rao Brief Repeatable Battery were used to classify the patients as cognitively deteriorating or stable or improving. RESULTS We identified 12 of 28 cognitively deteriorating and 16 of 28 stable or improving patients. These subgroups did not differ in the mean +/- SD percentage of brain volume changes (-2.1% +/- 1.2% vs -1.3% +/- 1.3%; P = .11), normalized deep gray matter volume changes (-2.1 +/- 2.8 mL vs -0.6 +/- 3.1 mL; P = .60), and changes in lesion load on T2-weighted MRIs (1.9 +/- 2.6 mL vs 1.6 +/- 2.3 mL; P = .73). However, NCV changes were significantly higher in deteriorating than in stable or improving patients (-43.0 +/- 18.9 mL vs -17.8 +/- 26.6 mL; P = .007). In deteriorating patients, NCV changes were correlated with performance in a verbal fluency test (r = 0.73; P < .001). In a regression model, only NCV changes were significantly associated with deteriorating cognitive performance (odds ratio, 0.8; 95% confidence interval, 0.7-0.9). CONCLUSION Progressive neocortical gray matter loss is relevant to MS-associated cognitive impairment and may represent a sensitive marker of deteriorating cognitive performance in RRMS.

[1]  B. Trapp,et al.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.

[2]  Frederik Barkhof,et al.  An fMRI study of planning-related brain activity in patients with moderately advanced multiple sclerosis , 2004, Multiple sclerosis.

[3]  M. Ron,et al.  Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow up study. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[4]  A. Morel.  THE THALAMUS AND BEHAVIOR: EFFECTS OF ANATOMICALLY DISTINCT STROKES , 2007, Neurology.

[5]  R. Bakshi,et al.  Frontal cortex atrophy predicts cognitive impairment in multiple sclerosis. , 2002, The Journal of neuropsychiatry and clinical neurosciences.

[6]  L. Amaducci,et al.  Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up. , 1995, Archives of neurology.

[7]  Robert Zivadinov,et al.  Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. , 2006, Archives of neurology.

[8]  P. M. Matthews,et al.  Evidence of early cortical atrophy in MS , 2003, Neurology.

[9]  Stephen M Rao,et al.  Cognitive dysfunction in multiple sclerosis: a review of recent developments. , 2003, Current opinion in neurology.

[10]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[11]  A. Thompson,et al.  A longitudinal study of cognition in primary progressive multiple sclerosis. , 2005, Brain : a journal of neurology.

[12]  Dieter Vaitl,et al.  Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing–remitting MS , 2006, NeuroImage.

[13]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[14]  Massimo Filippi,et al.  Multiple sclerosis: a white matter disease with associated gray matter damage , 2001, Journal of the Neurological Sciences.

[15]  H. Amièva,et al.  Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[16]  Frederik Barkhof,et al.  Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. , 2005, AJNR. American journal of neuroradiology.

[17]  G Cazzato,et al.  A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis , 2001, Journal of neurology, neurosurgery, and psychiatry.

[18]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[19]  P. Matthews,et al.  Normalized Accurate Measurement of Longitudinal Brain Change , 2001, Journal of computer assisted tomography.

[20]  W. Brück,et al.  Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. , 2000, Brain : a journal of neurology.

[21]  Roberto Mutani,et al.  Grey Matter Pathology in Multiple Sclerosis , 2005, Journal of neuropathology and experimental neurology.

[22]  J. Geurts,et al.  Grey matter pathology in multiple sclerosis , 2006, Acta neurologica Scandinavica. Supplementum.

[23]  N. De Stefano,et al.  Neocortical volume decrease in relapsing–remitting MS patients with mild cognitive impairment , 2004, Neurology.

[24]  S. Sorbi,et al.  Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. , 2001, Archives of neurology.

[25]  R I Grossman,et al.  Three-dimensional proton spectroscopy of deep gray matter nuclei in relapsing–remitting MS , 2004, Neurology.

[26]  B. Trapp,et al.  Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences , 2001, Current opinion in neurology.

[27]  Moses Rodriguez,et al.  Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis , 1998, Nature Medicine.

[28]  Caterina Mainero,et al.  fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis , 2004, NeuroImage.

[29]  R. Bakshi,et al.  T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. , 2002, Archives of neurology.

[30]  Rohit Bakshi,et al.  Thalamic Involvement in Multiple Sclerosis: A Diffusion‐Weighted Magnetic Resonance Imaging Study , 2003, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[31]  Paul M Matthews,et al.  Reduced brain functional reserve and altered functional connectivity in patients with multiple sclerosis. , 2006, Brain : a journal of neurology.

[32]  M. Bahr,et al.  Acute Neuronal Apoptosis in a Rat Model of Multiple Sclerosis , 2001, The Journal of Neuroscience.

[33]  P. Matthews,et al.  Thalamic neurodegeneration in multiple sclerosis , 2002, Annals of neurology.

[34]  Frederik Barkhof,et al.  Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. , 2005, Radiology.

[35]  R. Bakshi,et al.  Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis , 2006, Multiple sclerosis.

[36]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[37]  Rohit Bakshi,et al.  Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis , 2006, Neurology.

[38]  Max S. Cynader,et al.  Axonal cytoskeleton changes in experimental optic neuritis , 1999, Brain Research.

[39]  G. Barker,et al.  Emergence of thalamic magnetization transfer ratio abnormality in early relapsing—remitting multiple sclerosis , 2005, Multiple sclerosis.

[40]  Rohit Bakshi,et al.  Correlating Brain Atrophy With Cognitive Dysfunction, Mood Disturbances, and Personality Disorder in Multiple Sclerosis , 2004, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[41]  Robert Zivadinov,et al.  Semi-automatic brain region extraction (SABRE) reveals superior cortical and deep gray matter atrophy in MS , 2006, NeuroImage.

[42]  L. Grattan,et al.  The brief repeatable battery of neuropsychological tests for multiple sclerosis: a preliminary serial study , 1995, Multiple sclerosis.

[43]  R. Bakshi,et al.  Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients , 2001, Journal of the Neurological Sciences.

[44]  F. Barkhof,et al.  Cortical lesions in multiple sclerosis. , 1999, Brain : a journal of neurology.

[45]  J. Ruutiainen,et al.  The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up. , 1997, Brain : a journal of neurology.

[46]  My-Van Au Duong,et al.  Functional magnetic resonance imaging and cognition at the very early stage of MS , 2006, Journal of the Neurological Sciences.